Dr Joy Wolfram from the Mayo Clinic explains how nanomedicine has the potential to change the way we treat disease.

Filmed at the 2017 Hello Tomorrow Global Summit.

Joy Wolfram, Ph.D., focuses her research in nanomedicine on the development of new strategies for the treatment of disease. In particular, her team is developing extracellular vesicle therapeutics and methods for organotropic drug delivery. Dr. Wolfram aspires to generate fruitful interinstitutional research collaborations around the world.

The Nanomedicine and Extracellular Vesicles Laboratory of Joy Wolfram, Ph.D., at Mayo Clinic

www.hello-tomorrow.org

 

Recent News

A megalibrary of nanoparticles

Using straightforward chemistry and a mix-and-match, modular strategy, researchers have developed a simple approach that could produce over 65,000 different types of complex nanoparticles, each containing up to six [...]

Self-driving microrobots

Most synthetic materials, including those in battery electrodes, polymer membranes, and catalysts, degrade over time because they don't have internal repair mechanisms. If you could distribute autonomous microrobots within [...]